Based on these data, we propose that the APC/PAR-1 signaling pathway may be critical in protecting against CAD by reducing leukocyte–endothelium adhesion and vascular inflammation in the coronary arteries of PROCR-219Gly carriers (Fig. 6). The gene discussed is APC; the disease is coronary artery disorder.